Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

OBESITY AND FATTY LIVER DISEASE

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
THEMED DISCUSSION LEADER
John R. Koethe
Vanderbilt University Medical Center, Nashville, TN, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
BODY MASS INDEX AND THE RISK OF SERIOUS NON-AIDS EVENTS: THE D:A:D STUDY
Amit C Achhra
Kirby Institute, UNSW Australia; & NCB Hosp and JJP VA Med Ctr, New York, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
RANDOMIZED TRIAL OF BEHAVIORAL WEIGHT LOSS FOR HIV-INFECTED PATIENTS
Katie Becofsky
University of Massachusetts Amherst, Amherst, MA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
Predictors of Severe Weight/Body Mass Index Gain Following Antiretroviral Initiation
Priya Bhagwat
University of California, Los Angeles, Los Angeles, CA, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
RALTEGRAVIR SWITCH AND BIOMARKERS OF LIVER STEATOSIS AND METABOLIC SYNDROME IN WOMEN
Jordan E Lake
University Texas Houston, Houston, USA
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
CHANGES IN LIVER STEATOSIS AFTER SWITCHING EFAVIRENZ TO RALTEGRAVIR: THE STERAL STUDY
Juan Macías
Hospital Universitario de Valme, Sevilla, Spain
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 1:30 PM-2:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7